MeVis Medical Solutions Aktie
WKN DE: A0LBFE / ISIN: DE000A0LBFE4
|
21.08.2025 17:45:04
|
EQS-Adhoc: MeVis Medical Solutions AG: Forecast adjustment for the 2024/2025 fiscal year
|
EQS-Ad-hoc: MeVis Medical Solutions AG / Key word(s): Change in Forecast Bremen, August 21, 2025 – MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading provider of medical imaging software, is adjusting its forecast for the current fiscal year based on preliminary figures for the first ten months. For fiscal year 2024/2025 (October 1, 2024 to September 30, 2025), revenue is now expected to decline slightly to between €16.5 million and €17.0 million (previous forecast: €17.0 million to €17.5 million). MeVis expects EBIT (earnings before interest and taxes) to decline to between €3.0 million and €3.5 million (previous forecast: €3.5 million to €4.0 million). License sales are below expectations and cannot be offset by maintenance revenues and other revenues. ************************************************************************ Contact: Kirchhoff, Marcus / CEO End of Inside Information
21-Aug-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | MeVis Medical Solutions AG |
| Caroline-Herschel-Str. 1 | |
| 28359 Bremen | |
| Germany | |
| Phone: | +49 421 224 95 0 |
| Fax: | +49 421 224 95 999 |
| E-mail: | ir@mevis.de |
| Internet: | http://www.mevis.de |
| ISIN: | DE000A0LBFE4 |
| WKN: | A0LBFE |
| Listed: | Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2187294 |
| End of Announcement | EQS News Service |
|
|
2187294 21-Aug-2025 CET/CEST
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu MeVis Medical Solutions AGmehr Nachrichten
|
21.08.25 |
EQS-Adhoc: MeVis Medical Solutions AG: Prognoseanpassung für das Geschäftsjahr 2024/2025 (EQS Group) | |
|
21.08.25 |
EQS-Adhoc: MeVis Medical Solutions AG: Forecast adjustment for the 2024/2025 fiscal year (EQS Group) | |
|
27.05.25 |
EQS-News: MeVis publishes figures for the first half of fiscal year 2024/2025 (EQS Group) | |
|
27.05.25 |
EQS-News: MeVis veröffentlicht Zahlen für das erste Halbjahr im Geschäftsjahr 2024/2025 (EQS Group) |
Analysen zu MeVis Medical Solutions AGmehr Analysen
Aktien in diesem Artikel
| MeVis Medical Solutions AG | 25,20 | 2,44% |
|